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ABSTRACT

Knowledge, Attitudes and Practices of Healthcare Providers towards Prenatal HIV
Screening and Prevention of Mother-To-Child Transmission in Nigeria
L. Nneka Mobisson. Yale University School of Medicine. Department of Obstetrics &
Gynecology. New Haven, Connecticut
The purpose of this study was to assess the knowledge, attitudes and practices of
healthcare providers regarding prenatal HIV screening and the use of antiretroviral drugs
in the prevention of mother-to-child transmission of HIV in Nigerian pregnant women. A
cross-sectional survey using self-administered questionnaires among 150 healthcare
providers (physicians and nurses) was conducted at four healthcare facilities in Nigeria
from June to August 2000. Two of these healthcare facilities are the designated pilot
centers for the national prevention of mother-to-child-transmission (PMTCT) program.
Differences in responses between physicians and nurses were compared for each
category. Of 150 self-administered questionnaires that were fielded, 86 healthcare
providers responded, for a response rate of 57%. Less than two-thirds of respondents had
correct knowledge regarding the use of antiretroviral drugs in mother-to-child
transmission with physicians being more knowledgeable than nurses. Despite the
differences in knowledge levels, more nurses than physicians agreed on the importance of
screening pregnant women for HIV (93% vs. 70.91%; P=0.04). In addition, a
significantly larger proportion of nurses routinely inquire about the HIV status of
pregnant women (60% vs. 38%). Current healthcare providers have limited knowledge
levels regarding the use of antiretroviral drugs in the prevention of mother-to-child
transmission. In addition, a significant proportion of healthcare providers do not have
attitudes or practices conducive to the prevention of perinatal transmission. This may
negatively impact on the success of the PMTCT programs in Nigeria. This study
highlights the need for continuous and comprehensive training of healthcare providers at
government and private healthcare facilities to increase the likelihood of achieving the
objectives of PMTCT programs.
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INTRODUCTION

A. The HIV/AIDS Burden in Nigeria
Each year, an estimated 700,000 children around the world contract the HIV vims,
mostly through perinatal transmission. (1) The Sub-Saharan African region has the
largest proportion of these new infections. In the western world, such infections have
been reduced to a large extent by institution of antiretroviral regimens, elective cesarean
sections, and exclusive formula feeding. However, the institution of such programs in
developing countries has been extremely challenging due to the high cost and resource
requirements of such interventions.

In Sub-Saharan Africa, the countries hardest hit by the epidemic have been the
southern African countries such as South Africa, Botswana, and Zimbabwe where
prevalence rates range from 20.1% (2) to 38.8% (3). Equally alarming, however, is the
HIV/AIDS situation in West African countries such as Nigeria. There are an estimated
3.5 million Nigerians living with HIV/AIDS and it currently has the third largest number
of HIV-positive people in the world (4). The prevalence of HIV in Nigeria, although
remaining comparatively low, has steadily increased over the last decade. According to
the Nigerian Federal Ministry of Health Sentinel sero-sentinel surveys, the prevalence of
HIV in Nigeria has risen from 1.8% in 1991 to 5.8% in 2001 (5,6). This prevalence rate is
projected to increase to 15% by 2010 (7) (Figure 1).
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FIGURE 1. Nigeria’s HIV Prevalence. Nigerian Federal Ministry of Health. 2001.

The overall percentage of HIV-positive people in Nigeria may appear small in
comparison with other Sub-Saharan countries like South Africa and Botswana. However,
Nigeria is the most populous country in sub-Saharan Africa with over 123 million
residents. As such, the absolute number of HIV-infected Nigerians is high.

B. Prevalence of HIV in pregnant women and children

The median prevalence of HIV disease in urban and rural antenatal clinics increased from
1% in 1991 to 5% in 1999 (8). As of 2001, prevalence rates at antenatal clinics were as
high as 10% in some states in Nigeria (9). Numbers currently do not exist for the
estimated percent of Nigerian HIV-positive pregnant women because of the lack of
routine voluntary counseling and testing. However, it is estimated that one out of eight
pregnant women is HIV-positive (10). With an average fertility rate of 6 births per
Nigerian woman (11), the number of HIV cases resulting from perinatal transmission is

7

expected to increase significantly. According to UNICEF, an estimated 4.7 million
pregnancies occur in Nigeria every year and, with an estimated 45% perinatal
transmission rate (12), approximately 220,000 HIV-positive children will be born each
year. As of 2002, there were an estimated 750,000 children who were HIV-positive (13).
Since HIV/AIDS is largely spread by heterosexual transmission, it is likely that the
majority of these children contracted the virus by perinatal transmission.

An underrepresented story of the Nigerian HIV/AIDS epidemic is the issue of
AIDS orphans. At the end of 2001, an estimated 1 million children under the age of 15
were orphaned as a direct consequence of the epidemic. This number is projected to
increase to 2.5 million by 2010. (14) Although it is concerning that Nigeria does not
possess the systems and structures necessary to care for healthy orphans, the burden of
caring for HIV-positive orphaned children will be much greater. These projections
highlight the necessity of comprehensive Prevention of Mother-to-Child Transmission
(PMTCT) programs to reduce the number of HIV-positive orphans who contract the virus
through perinatal transmission.

C.

Government Efforts and Policies

During the beginning stages of the epidemic in Nigeria in the early 1990’s, the
government did very little. Prior to this, almost all of the efforts against HIV were
conducted by the numerous Non-Governmental Organizations (NGOs) throughout the
country. However, with the advent of civilian rule in 1999 when Mr Olusegun Obasanjo
became president of Nigeria, the government’s response to the HIV/AIDS epidemic
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increased significantly. The government decided to make HIV/AIDS a national priority
and consequently established a national body known as NACA (Nigerian Action
Committee Against AIDS) to formulate and implement policy to address the HIV/AIDS
situation. In 2001, NACA developed a 3-year strategic plan, the HIV/AIDS Emergency
Action Plan (HEAP), to address the HIV/AIDS situation. One of the sub-strategies
identified in the HEAP Plan was to implement an extensive PMTCT program to address
the growing number of HIV-positive children that were contracting the virus via perinatal
transmission. At the time, the only option available to HIV infected pregnant women was
termination of pregnancy. Most women were unaware of their status and so did not do
anything to prevent vertical transmission (15).

I). Prevention of Maternal to Child Transmission (PMTCT)
Perinatal HIV transmission without antiretroviral drug intervention is estimated to range
from 14 to 48% (16). In 1994, Pediatric AIDS Clinical Trial Group protocol 076
(PACTG 076) showed that administration of zidovudine to HIV-infected women during
pregnancy, labor and to the newborn for at least 6 weeks after delivery reduced perinatal
transmission by almost two-thirds (from 25.5% to 8.3%) among women who did not
breastfeed (17). Subsequently, the HIVNET-012 trial showed that peripartum nevirapine
was a more cost-effective regimen for PMTCT in resource-poor countries. This study
showed that a combination of nevirapine and earlier weaning would decrease perinatal
transmission to approximately 15% at 5 years (18).
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The combination of HIV screening, counseling, and antiretroviral drug
administration has dramatically reduced mother-to-child transmission of HIV in western
countries (19,20). In the developing world, however, the uptake of PMTCT programs has
been inadequate due to deficiencies in staff and resources, logistical problems such as
high import duties on the drugs, and lack of funds. In July 2000, the German based
company Boehringer Ingelheim pledged to donate the drug nevirapine to all
governments, individuals, NGOs or private organizations in World Bank classified “leastdeveloped” countries which agreed to institute a PMTCT program. Over the first couple
years, there was a slow initial uptake by the countries, which was attributed to problems
with logistics and staff supply.

However, as of August 2003, 44 countries from Africa,

Eastern Europe, Asia, and the Caribbean had taken up Boehringer Ingelheim’s donation.
Nigeria became a recipient of this drug donation program in November 2001.

E. Nigeria’s National PMTCT Program
As pail of the Nigerian Emergency Action Plan, a national policy was formulated with
the objective of implementing a comprehensive PMTCT system of antenatal HIV
counseling and testing and antiretroviral treatment. Although the PMTCT program was
scheduled to be launched in 2001, it was delayed because of financial and ethical
obstacles. The PMTCT program was finally initiated at 8 pilot centers in June 2002. The
pilot centers are all located at teaching hospitals throughout the country. These include:
(1) Ahmadu Bello University Teaching Hospital Zaria, Kaduna; (2) University of
Maiduguri, Borno; (3) Lagos University Teaching Hospital, Lagos; (4) University of
Nigeria Teaching Hospital, Enugu; (5) National Hospital, Abuja; (6) Jos University
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Teaching Hospital, Jos; (7) University of Port Harcourt Teaching Hospital, PortHarcourt; and (8) University College Hospital Ibadan, Oyo. (Figure 2)

FIGURE 2: Location of Pilot Centers (Reproduced from www.greenwichmeantime.com)

The program aims to treat pregnant mothers using the HIVNET 012 regimen (one dose of
oral nevirapine 200 mg at the onset of labor followed by a dose of 2 mg/kg orally to the
child within 3 days of birth). In addition, all mothers (and HIV-positive children) are
eligible to receive free antiretroviral treatment after delivery. The stated goal is to treat
5,000 HIV-positive pregnant women by 2004. As of 2002, only 141 HIV-positive women
had been enrolled in the national PMTCT program. This represents only 1 of every 2,000
HIV-positive pregnant women. In an attempt to reach more HIV-positive pregnant
women, other organizations such as Family Health International, an international NGO,
have plans to launch additional PMTCT sites in different Nigerian states.

F. Challenges with PMTCT Programs
Despite the relative efficiency of antiretroviral drugs in reducing perinatal transmission,
complete prevention of MTCT transmission is predicated on a number of external factors
such as a system of antenatal testing, continuous drug availability during labor and in the
immediate postpartum period, and the awareness and willingness of healthcare providers
to recruit or diagnose HIV-positive women. This action requires that healthcare providers
not only provide counseling and testing consistently, but also maintain the appropriate
knowledge regarding perinatal transmission and chemoprophylaxis in HIV-positive
pregnant women (21). It is not surprising, therefore, that studies have shown that the
attitudes, values, and knowledge of health care providers can play a huge part in the
health outcomes of their patients partly due to the way in which they present and discuss
issues with patients. (22)

G. Knowledge, Attitudes and Practices of healthcare providers towards people living
with HIV/AIDS.
Several studies have been done on a global level to document the knowledge, attitudes
and practices of healthcare providers towards people living with HIV/AIDS. In the early
1990’s, there was a low level of knowledge and widespread negative attitudes among
majority of healthcare providers towards such patients. Since then, however, there has
been a trend towards increased basic knowledge levels and more positive attitudes
towards people living with HIV/AIDS. This has been attributed in large part to extensive
training of healthcare providers. However, there has been little data collected on the
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knowledge, attitudes, and practices of providers regarding the PMTCT services. This
dearth of information provided the impetus for the implementation of our study. More
recently, a large-scale study to examine the role of attitudes and practices of healthcare
providers on PMTCT programs was initiated by the Quality Assurance Project in
Rwanda.

Healthcare providers are essential players in educating society about HIV/AIDS
prevention and transmission. In addition, these providers play a pivotal role in the care
and treatment of people living with HIV/AIDS in Nigeria. Healthcare providers are
subject to a higher risk of infection when caring for HIV infected or AIDS patients.
Consequently, fears of infection and general perceptions may serve as a barrier to the
provision of care to such patients and their families. Oftentimes, health care providers
may deny people living with HIV/AIDS access to healthcare because of the perception
that they have HIV/AIDS.

A recent study conducted in Lagos, Nigeria demonstrated

that only 18% of healthcare providers would visit a person living with HIV/AIDS while
only 53% would be willing to work in the same office as such a person. These numbers
are particularly alarming when interpreted in the context of a nationally sanctioned
PMTCT program. To make this type of a program successful, healthcare providers will
undoubtedly have to play a major role in encouraging HIV-positive pregnant women to
take nevirapine to decrease the risk of HIV transmission to their children. To increase the
enrollment of pregnant women into the voluntary counseling and testing program, it is
imperative that healthcare providers are informed and sensitized to this particular
population. Studies are currently being conducted by the Quality Assurance Project to
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examine the impact of HIV/AIDS stigma among healthcare providers on the quality of
care provided in PMTCT services. These studies are being carried out in Rwanda,
Tanzania, and Haiti to assess HIV knowledge, attitudes, and practices of health providers
as a first step towards designing interventions to reduce stigma.

In order to improve the health status of Nigerian HIV-positive pregnant women and to
decrease perinatal transmission of HIV infection, the relationship between knowledge of
PMTCT and attitudes and practices concerning prenatal screening and antiretroviral drug
administration should be explored. There are currently no published studies on the
knowledge and attitudes of Nigerian health care providers towards pregnant women with
HIV/AIDS. Our study aims to evaluate the knowledge and attitudes of Nigerian health
care providers towards prenatal screening and PMTCT in Nigerian pregnant women.

STATEMENT OF PURPOSE AND HYPOTHESIS
The purpose of this study was to assess the knowledge, attitudes, and practices of
healthcare providers towards antenatal HIV screening and the prevention of mother-tochild transmission of HIV in Nigerian pregnant women. We surveyed physicians and
nurses at three teaching hospitals and four private hospitals in Nigeria on their views and
practices regarding HIV testing in pregnant women and the use of antiretroviral therapy
to prevent perinatal transmission. The teaching hospitals comprise two of the eight
designated pilot centers for the national PMTCT program.
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We hypothesized that Nigerian healthcare providers’ level of knowledge of motherto-child transmission would be low and their attitudes towards antenatal HIV screening
would hinder the success of the nationally sanctioned PMTCT program. The aims of the
study were:
(1) To define the providers attitudes towards pregnant women with HIV,
(2) To document their knowledge of mother-to-child transmission of the HIV virus, and
(3) To assess the impact of their knowledge, attitudes, and practices on the feasibility of
the nationally sanctioned PMTCT program.

METHODS
We performed an anonymous cross-sectional survey of healthcare providers at three
major teaching hospitals and four private health care facilities in Nigeria. Institutional
Review Board approval was obtained from the Yale University School of Medicine. The
teaching hospitals were: Gwawaladja Hospital in Abuja, the Federal Capital Territory and
Lagos University Teaching Hospital in Lagos, and the University of Nigeria Teaching
Hospital in Enugu. The private hospitals were located in Lagos: Schubbs Dental Clinic,
Child Care Pediatrics, International Medical Group (IMG), and Life Support Clinic . We
chose to survey an array of healthcare providers including both nurses and physicians,
because this group of professionals is responsible for counseling pregnant women before
and after HIV testing, for performing the HIV test, and for administering the medication.
The physicians surveyed were family practitioners and obstetrician-gynecologists. This
group of healthcare providers caters to most pregnant women who seek antenatal care in
urban Nigeria. They are in a unique position to reduce HIV perinatal transmission by

15

screening pregnant women, identifying those who are HIV-positive, and offering
antiretroviral therapy to them in order to decrease the incidence of pediatric HIV/AIDS
by mother-to-child transmission.

A total of 150 self-administered 12-question surveys were fielded at the 7 different
health care facilities and there was a response rate of 57.3% (86 surveys were returned).
Survey questions included provider knowledge about facility testing capabilities and
utility of antiretroviral therapy in PMTCT as well as provider attitudes and behavior
regarding HIV screening in pregnant women. The surveys were fielded from June to July
2000.

There were 3 or less respondents at three of the hospitals surveyed, including
Scrubbs Dental Clinic, IMG, and ChildCare Pediatrics. As such, the data from these
respondents (9 in total) were removed from the analysis. In addition, three laboratory
technologists erroneously filled out the survey and their data too was excluded from the
analysis. This gave an overall response rate of 51.3% (77 out of 150 respondents). Chisquare tests for proportions were used to evaluate significance of difference between the
categorical variables. A significance level of 0.05 was used for the data analysis.

RESULTS

Physicians Knowledge
Questions

Yes

No

No Answer

Number (%)

Number {%)

Number (%)

1. HIV Testing is available in their work area

53/55 (96.3)

2/55 (3.6)

2. Results of HIV testing are available in 24 hours

29/55 (52.7)

26/55 (47.2)

3. Results of HIV testing are available in 6 hours.

14/55 (25.4)

40/55 (72.7)

1/55 (1.8)

4. HIV medications can be used safely during pregnancy

35/55 (63.6)

10/55 (18.1)'

10/55 (18.1)

5. HIV medications can be used safely during labor

37/55 (67.2)

7/55 (12.7)

11/55 (20.0)

6. Treatment with ATT during labor reduces maternal to

36/55 (65.4)

6/55 (10.9)

13/55 (23.6)

29/55 (52.7)

14/55 (25.4)

child transmission of HIV.
7. HIV medications given to pregnant women cause fetus

12/55 (21.8)

harm

Physician's knowledge of the availability of HIV testing facilities at their respective
hospitals was high, with 96.4% of the physicians aware that testing was available at their
centers. However, their knowledge of the timing of results was low. Discussion with the
clinical laboratories at each of the centers confirmed that, at all the centers, HIV test
results were available an average of 72 hours later. There were no centers where HIV test
results were available in 24 hours or 6 hours. Only 47.3% (26/55) of physicians were
aware that test results were not available in 24 hours, while 72.7% (40/55) of physicians
were aware that rapid testing was not available (these results were not available in 6
hours). 63.7% (35/55) knew that HIV medications could be used safely during
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pregnancy, while 67.3% (37/55) knew that HIV medications could be used safely during
labor. Overall, 65.5% (36/55) knew that AZT could be used to reduce maternal to child
transmission of HIV, while only 52.7% (29/55) believed that HIV medications do not
cause harm to the fetus.

Physicians Attitudes
Yes

No

No Answer

Number (%)

Number (%)

Number (%)

1. Pregnant Women should be screened for HIV during pregnancy

49/55 (89.1)

10.91%

2. Pregnant women should be screened for HIV during labor if their

39/55 (70.9)

14/55 (25.5)

50/55 (90.9)

5/55 (9.1%)

Questions

2/55 (3.6)

status is unknown or was not tested during pregnancy
3. Important to know HIV status of women during pregnancy

In terms of physician’s attitudes, 89.1% (49/55) felt that women should be screened for
HIV during pregnancy while 70.9% (39/55) believed that women should be screened for
HIV during labor if they had not been tested during pregnancy. In addition, 90.9%
(50/55) felt that it was important to know the HIV status of women during pregnancy.

Physician Practices
Questions

Yes
Number (%)

No
Number (%)

No Answer
Number (%)

I. Most women they take care of are HIV-positive.

1/55 (1.8)

53/55 (96.4)

1/55 (1.8)

2. They routinely inquire about maternal HIV status at labor onset

21/55 (38.2)

29/55 (52.7)

5/55 (3.6)
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Most of the physicians surveyed said that they do not take care of HIV-positive women.
Most respondents said they do not take care of HIV-positive women (96.4%) while one
respondent said she did and one respondent gave no answer.
Nurses Knowledge

Yes

No

No Answer

Number (%)

Number (%)

Number (%)

/. HIV Testing is available in tlieir work area

100%

-

2. Results of HIV testing are available in 24 hours

14/15 (93.3)

1/15 (6.7)

-

3. Results of HIV testing are available in 6 hours.

8/15 (53.3)

7/15 (46.7)

~

4.HIV medications can be used safely during pregnancy

4/15 (26.7)

5/15 (33.3)

6/15 (40)

5. HIV medications can be used safely during labor

4/15 (26.7)

5/15 (33.3)

6/15 (40)

6. Treatment with AZT during labor reduces maternal to child

7/15 (46.7)

3/15 (20)

5/15 (33.3)

4/15 (26.7)

6/15 (40)

Questions

transmission of HIV.
7. HIV medications given to pregnant women cause fetus harm

5/15 (33.3)

Unlike physicians, all nurses knew that HIV testing is available in their work area. Only
6.7% (1/15) knew that results of HIV testing were not available within 24 hours while
only 46.7% (7/15) knew that results of HIV testing were not available within 6 hours.
Only 26.7% (4/15) of nurse respondents knew that HIV medications might be used safely
during pregnancy and during labor. In addition, only 46.7% (7/15) of respondents knew
that treatment with AZT during pregnancy reduces MTCT. Lastly, one quarter (26.7%) of
nurses believed that HIV medications causes harm to the fetus.
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Nurses Attitudes
Questions

Yes

No

No Answer

Number (%)

Number (%)

Number (%)

1. Pregnant Women should be screened for HIV during pregnancy

15/15 (100)

2. Pregnant women should be screened for HIV during labor if their

14/15 (93.3)

1/15 (6.7)

-

15/15 (100)

"

-

status is unknown or was not tested during pregnancy
3. Important to know HIV status of women during pregnancy

Unlike physicians, all nurse respondents felt that pregnant women should be screened for
HIV during pregnancy. In addition, 93.3% (14/15) of nurses felt that women should be
screened for HIV during labor if they were not tested during pregnancy. All nurses felt
that it was important to know HIV status of women during pregnancy.

Nurses Practices
Questions

Yes

No

No Answer

Number (%)

Number t%)

Number (%)

1. Most women they take care of are HIV-positive.

1/15 (6.7)

14/15 (93.3)

-

2. They routinely inquire about maternal HIV status at labor onset

9/15 (60)

4/15 (26.7)

2/15 (13.3)

Overall, a larger proportion of nurses appeared to believe that the women they served
were HIV-positive and were more likely to inquire about HIV status at labor onset than
physicians.

There were significant differences between the physicians and nurses regarding their
knowledge of the HIV testing capabilities of their facilities (p=0.004). There was also a
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significant difference between the proportion of physicians and nurses who knew that
antiretroviral medications could be used safely during pregnancy and during labor.
(p^O.Ol; p=0.004 respectively). The differences between physicians and nurses’ level of
knowledge regarding the other areas of mother-to-child transmission were not statistically
significant. (Figure 3)

100.00%

90.00%
80.00%
70.00%
60.00%
50.00%
40.00%
30.00%

□ Physicians
■ Nurses

20.00%
10.00%
0.00%

Avail Of
Results
Results
HIV meds
HIV meds Tx with AZT HIV meds
HIV testing available in avail in 6h used safely used safely reduces cause fetus
24h
during labor
during
MTCT
harm
pregnancy

FIGURE 3: Comparison of physicians and nurses level of knowledge.

Across the four hospitals surveyed, there were differences in levels of knowledge,
attitudes, and practices between healthcare providers:

University Teaching Hospital (l NTH)
Providers ’ Knowledge

At UNTH, 92.6% (25/27) of healthcare providers knew that HIV testing is available in
their work area. 55.6% (15/27) of respondents knew that results of HIV testing were not
available within 24 hours while only 77.8% (21/27) knew that results of HIV testing were
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not available within 6 hours. Only 55.6% (15/27) of respondents knew that HIV
medications may be used safely during pregnancy and 59.3% (16/27) of respondents
knew that these medications could be used safely during labor. In addition. 74.1% (20/27)
of respondents knew that treatment with AZT during pregnancy reduces mother-to-child
transmission. Lastly, 48.2% (13/27) believed that HIV medications cause fetuses harm.

Providers Attitudes

Twenty-five respondents (92.6%) felt that pregnant women should be screened for HIV
during pregnancy. However, 74.1% (20/27) of respondents felt that women should be
screened for HIV during labor if they were not tested during pregnancy. Majority of
respondents (92.6%) felt that it was important to know HIV status of women during
pregnancy.

Providers Practices

Less than half of respondents (40.7%) said that they routinely inquire about the HIV
status of pregnant women. Only one respondent stated that most of the women he took
care of are HIV-positive. Although data does not exist for the prevalence of HIV-positive
patients who attend the different healthcare facilities, there are numbers for the
prevalence rates at antenatal centers in different regions. In Enugu state where UNTH is
located, the HIV prevalence rate in 1999 was estimated to be 4.7% (23).
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Lagos University Teaching Hospital (LUTH)
Providers ’ Knowledge

At LUTH, out of 13 respondents, 100% of healthcare providers knew that HIV testing is
available in their work area. Yet, only 33.8% (4/13) of respondents knew that results of
HIV testing were not available within 24 hours while 69.2% (9/13) knew that results of
HIV testing were not available within 6 hours. Only 53.9% (7/13) of respondents knew
that HIV medications may be used safely during pregnancy and 46.2% (6/13) of
respondents knew that these medications could be used safely during labor. In addition,
46.2% (6/13) of respondents knew that treatment with AZT during pregnancy reduces
mother-to-child transmission. Lastly, 46.2% (6/13) knew that HIV medications do not
cause fetuses harm.

Providers Attitudes

Nine respondents (69.2%) felt that pregnant women should be screened for HIV during
pregnancy. However, only 7 respondents (53.9%) felt that women should be screened for
HIV during labor if they were not tested during pregnancy. Ten respondents (76.9%) felt
that it was important to know HIV status of women during pregnancy.

Providers Practices

All respondents denied that the majority of patients they take care of are HIV-positive yet
only 38.5% (5/13) of respondents said that they routinely inquire about the HIV status of
pregnant women. The HIV prevalence rate in Lagos state was estimated to be 6.7% in
1999 (24).
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Gwawaladja Teaching Hospital
Providers ’ Knowledge

At Gwaradja, out of 20 respondents, 100% of healthcare providers knew that HIV testing
is available in their work area. Yet, only 43.5% (9/20) of respondents knew that results of
HIV testing were not available within 24 hours while 87% (17/20) knew that results of
HIV testing were not available within 6 hours. Approximately 73.9% (15/20) of
respondents knew that HIV medications might be used safely during pregnancy and
during labor. In addition, 73.9% (15/20) of respondents knew that treatment with AZT
during pregnancy reduces mother-to-child transmission. Lastly, 34.8% (7/20) knew that
HIV medications do not harm the fetus.

Providers Attitudes

Most respondents (95.65%) felt that pregnant women should be screened for HIV during
pregnancy. However, fewer respondents (16/20) felt that women should be screened for
HIV during labor if they were not tested during pregnancy. The majority of respondents
(19/20) felt that it was important to know HIV status of women during pregnancy.

Providers Practices

Only 1 respondent claimed to serve predominantly HIV-positive patients while a little
more than half of respondents (52.2%) routinely inquire about the HIV status of their
patients. The HIV prevalence rate in Abuja was determined to be 7.2% in 1999. (25)
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Life Support Center
Providers ’ Knowledge

At Life Support Center, out of 13 respondents, 100% of healthcare providers knew that
HIV testing is available in their work area. Yet, no respondents knew that results of HIV
testing were not available within 24 hours and none of the respondents knew that results
of HIV testing were not available within 6 hours. Only 23.1% (3/13) of respondents knew
that HIV medications might be used safely during pregnancy during labor. In addition,
only 30.8% (4/13) of respondents knew that treatment with AZT during pregnancy
reduces mother-to-child transmission. Lastly, only 15.4 % (2/13) knew that HIV
medications do not harm the fetus.

Providers Attitudes

All respondents felt that pregnant women should be screened for HIV during pregnancy.
Most respondents (92.3%) felt that women should be screened for HIV during labor if
they were not tested during pregnancy. All respondents felt that it was important to know
HIV status of women during pregnancy.

Providers Practices

All respondents denied that the majority of patients they take care of are HIV-positive yet
only 38.5% (8/13) routinely inquire about the HIV status of their patients. The
prevalence rate of HIV in Lagos state (where Life Support is located) is 6.7%. (26)
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DISCUSSION
The 2002 UNAIDS Update stressed that, given its large population and an HIV
seroprevalence rate of 5.8%, Nigeria is one of four countries in the world with the largest
number of people living with HIV/AIDS (27). Indeed, Nigeria’s 3.5 to 4 million cases of
HIV account for almost one-tenth of the HIV/AIDS cases worldwide. Furthermore, the
federal government projects that, by the end of 2004, there will be an additional 500,000
new cases of HIV with 350,000 cases occurring in mainly reproductive age women.
When these numbers are interpreted within the context of maternal-to-child transmission,
they indicate that - in the absence of medical and social intervention - the number of
children born with HIV is likely to increase substantially. The provision of antiretroviral
prophylaxis to HIV-positive pregnant woman is one of the critical elements to mitigating
this aspect of the epidemic and reducing the number of children born with HIV. The
recent efforts by the national government, the private sector, and the civil society to
institute PMTCT programs throughout Nigeria are undoubtedly a major step to reduce the
number of perinatally transmitted HIV cases. However, if healthcare providers are not
well informed about basic HIV/AIDS knowledge and if their attitudes about the viability
of screening HIV-positive pregnant women and offering antiretroviral therapy to such
women to prevent perinatal transmission remain negative, then the utility of such
programs will certainly be impaired.

Our survey indicates that two-thirds (65.5%) of all physician respondents were
knowledgeable about the utility of antiretroviral drugs in preventing the transmission of
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HIV from mother to child. Furthermore, only half (52.7%) of all physician respondents
were aware that such drugs would not cause the fetus harm. It is alarming that at one of
the major PMTCT centers and one of the premier teaching centers in the country, LUTH,
less than half of both physician and nurse respondents were aware that treatment of the
mother with AZT reduces mother-to-child transmission of HIV and that HIV medications
can be used safely during labor. These numbers were only slightly higher at UNTH,
another top teaching hospital and national PMTCT center. At the private center. Life
Support, the level of knowledge was very low. Nigerian teaching hospitals usually are
more up to date with new research findings; however, physicians who practice at such
hospitals usually supplement their earnings by practicing at private hospitals. The
expectation is that this dual-job lifestyle of academic physicians benefits the private
hospitals through the provision of current medical information and research to these
hospitals. The low levels of knowledge at the private medical center suggest that more
center-specific training is needed for healthcare providers. This lack of knowledge among
providers may prove to be a major barrier in the identification of pregnant women who
are HIV-positive and could facilitate the growing number of HIV-infected children being
born each day.

Nurses also appear to have a very low level of knowledge, which has been replicated in
numerous studies (28). However, a larger proportion of the nurses appeared to have
attitudes and behavior more conductive to identifying HIV-positive women.

The

majority believed that it is important to know the HIV status of women and report that
they routinely inquire about the status of the women they see. As can be seen in Figure 3,
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despite the larger proportion of positive attitudes and practices among nurses, physicians
had higher levels of knowledge than the nurses.

The significant differences in the level of knowledge between physicians and nurses
highlights the need for programs designed for both types of healthcare providers.
Although the baseline level of knowledge for either type of healthcare provider is
unacceptable, the fact that nurses have lower levels of knowledge than physicians should
be addressed by the creation of education and training programs specific for them.

Given that healthcare providers are in a unique position to identify pregnant women
with HIV and to consequently offer a means for them to reduce the likelihood of
transmitting the virus to their newborns, it is concerning that they have such a low level
of knowledge. Since the study was done before the implementation of the national policy
on the establishment of 8 PMTCT centers, it is possible that subsequent training has led
to improvements in the AIDS-related knowledge, attitudes, and practices among
healthcare providers in Nigeria. However, the National Action Committee on AIDS
(NACA) did state that they have had difficulty in the establishment of these centers, and
cited a lack of adequate training as one of the major barriers to the institution of the
centers.

It is imperative that all healthcare providers who will influence a pregnant woman’s
decision to be screened for HIV and to receive antiretroviral prophylaxis should receive
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comprehensive training on basic AIDS-related information and on HIV/AIDS disease
management.

Prior to the institution of the PMTCT programs, healthcare providers may have
been uncomfortable with inquiring about the status of their patients because they felt that
there were no treatment options available for them. Although exclusive breastfeeding and
elective cesarean procedures are also effective in reducing perinatal transmission, these
options are not readily available to women in resource-poor countries. Exclusive formula¬
feeding requires continuous access to and availability of clean water, a rarity in many
developing countries. Women in these countries often cannot afford to purchase formula,
thus breast milk is usually the only available source of nutrition for the child. An
exclusively formula-fed child in a region without access to safe water is at increased risk
of malnutrition and diarrhea. In addition, stigmatization of women who exclusively
formula-feed in developing countries is often a deterrent to women who consider
discontinuing breast-feeding. Elective caesarean procedures are not feasible for the
general population in resource-poor regions given that most women deliver at home and
not in the hospital. For the women who do deliver in the hospital, c-sections are an added
expense that they often cannot afford. In addition, few hospitals in Nigeria have adequate
staffing, surgical supplies, drugs, and blood products that would be necessary. As such,
the provision of antiretroviral drugs to mothers and infants is the most feasible
intervention to significantly reduce perinatal transmission in Nigeria.
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Since many providers were unaware that antiretroviral drugs can be used to reduce
the risk of perinatal transmission, they likely believed there was little utility in asking
about the status of their patients. This is the reason often given when healthcare providers
are asked why they do not inquire about the HIV status of their patients. Given that
healthcare providers are often considered to be the largest perpetrators of stigma towards
people living with AIDS, it is possible that the providers did not want to know the HIV
status of their patients because of their own stigmatization of persons living with
HIV/AIDS.

At the private healthcare facility. Life Support Center, most respondents felt that it
was important to know the HIV status of pregnant women. This was particularly
interesting since a low number of these same respondents (25%) believed that treatment
with AZT could reduce the risk of delivering an HIV-positive child.

Limitations of our study include the relatively low response rate, which may impede
our ability to generalize these results to all healthcare providers in Nigeria. In addition,
the survey questionnaire did not elicit the demographic or specialty details of the
physicians. The lack of HIV-prevalence specific data at each health care center made it
difficult to compare the actual demographics of the patient populations with the selfreports of the healthcare providers. In addition, we did not investigate the reasons for the
negative attitudes on the part of the healthcare providers. Despite these limitations, the
survey gives credence to the need for comprehensive and continuous training of
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healthcare providers regarding their knowledge and attitudes toward HIV screening and
antiretroviral treatment of pregnant women.

The low knowledge levels and negative attitudes and practices of healthcare
providers towards pregnant women with HIV are major barriers to the success of the
nationally sanctioned PMTCT programs in Nigeria. Nigeria’s HIV epidemic is projected
to worsen significantly in the next few years. The burden of the epidemic can be
mitigated, at least in part, by reducing the mother-to-child transmission of HIV through
the identification of HIV-positive pregnant women and the use of antiretroviral
prophylaxis to them during labor. Healthcare providers in Nigeria must receive adequate
and continuous comprehensive AIDS-related training in order for these PMTCT
programs to be successful.

31

REFERENCES

1 UNAIDS. AIDS Epidemic Update. December 2003.
2 UNAIDS. South Africa Epidemiological Fact Sheet 2002
3 UNAIDS. Botswana Epidemiological Fact Sheet 2002
4 UNAIDS 2002, Report on the Global HIV/AIDS Epidemic
5 UNAIDS/WHO Epidemiological Fact Sheet 2002.
6 Nigeria Federal Ministry of Health Sero-Sentinel Survey, 2001
7 UNAIDS. Report on the Global HIV/AIDS Epidemic 2002
8 Nigeria Federal Ministry of Health Sero-Sentinel Survey, 2001
9 World Bank. The Next Wave of HIV/AIDS. 2002
10 http://www.democracyw-africa.org/mtctaiticle
11 Nigeria Demographic and Health Survey. 1999
12 Nolan, M., Greenberg, A. and Fowler, M. A review of clinical trials to prevent
mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies.
AIDS 2002, 16:1991-1999
13 UNAIDS. Report on the Global HIV/AIDS Epidemic. 2002
14 UNICEF and UNAIDS. 2002 Children on the brink 2002: a joint report on orphan
estimates and program strategies
15 Federal Government of Nigeria HIV/AIDS Emergency Action Plan 2001 3.2.1.4 Sub
strategy 5.4. Prevention of Infection through MTCT
16 De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV
transmission in resource-poor countries: translating research into policy and practice.
JAMA 2000,283:1175-82.
17 Conner EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of
human immunodeficiency virus type 1 with zidovudine treatment. New England Journal
of Medicine 1994, 331:1173-80.

32

18 Nolan, M. et al. A Review of Clinical Trials to prevent Mother to Child HIV-1
Transmission in Africa and inform rational intervention strategies. AIDS 2002. 16:19911999.
19 Mayaux MJ et al. Acceptability and impact of zidovudine for prevention of mother-tochild human immunodeficiency virus-1 transmission in France. Journal of Pediatrics
1997; 131:857-62
20 Shaffer, N et al. Technical Report: perinatal Human Immunodeficiency virus testing
and prevention of transmission. Committee on Pediatric AIDS. Pediatrics 2000; 106 E88
21 Conner, E.M et al. Reduction of maternal-infant transmission of human
immunodeficiency virus type 1 with zidovudine treatment. New England Journal of
Medicine 1994. 331:1173-80
22 Seguardo, A.; Miranda, S. and Latorre, M. Evaluation of the Care of Women Living
with HIV/AIDS in Sao Paulo, Brazil. AIDS Patient Care and STDs 2003 17: 85-93
23 Federal Ministry of Health, National AIDS/STI Control Program 2001
24 Federal Ministry of Health, National AIDS/STI Control Program 2001
25 Federal Ministry of Health, National AIDS/STI Control Program 2001
26 Federal Ministry of Health, National AIDS/STI Control Program 2001
27 www.nigeriafirst.org/uploads.aids.pdf Combating the HIV/AIDS Scourge in Nigeria
28 Plant, M. and Foster, J. AIDS-related experience, knowledge, attitudes and beliefs
amongst nurses in an area with a high rate of HIV infection. Journal of Advanced
Nursing 1993 18:80-88

33

ADDENDUM
Questionnaire for Health Care Providers on HIV Testing
Hospital_
Occupation_
YES

NO

1.

HIV testing is available in my work area.

Y

N

2.

Results of HIV testing are available within 24 hours.

Y

N

3.

Results of HIV testing are available within 6 hours.

Y

N

4.

Most women that 1 take care of are HIV positive.

Y

N

5.

Pregnant women should have HIV testing during their pregnancy.

Y

N

6.

If a pregnant woman has not had HIV testing during the pregnancy,
she should have testing when she comes into labor.

Y

N

7.

It is important to know HIV status of women during their pregnancy.

Y

N

8.

I routinely inquire about maternal HIV status at the onset of labor.

Y

N

9.

HIV medications can be used safely by a woman during pregnancy.

Y

N

10. HIV medications can be used safely during labor.

11. Treatment for HIV during labor with AZT reduces the transmission of
the HIV virus from mother to child.

12. HIV medications given to women when they are pregnant cause harm
to the fetus.

Y

Y

Y

N

N

N
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